Latest Insider Transactions at Resmed Inc (RSMDF)
This section provides a real-time view of insider transactions for Resmed Inc (RSMDF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RESMED INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RESMED INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2026
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.14%
|
$241,000
$241.75 P/Share
|
|
Jan 02
2026
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
50
-0.51%
|
$12,050
$241.75 P/Share
|
|
Dec 08
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Open market or private sale
|
Direct |
4,991
-1.06%
|
$1,252,741
$251.41 P/Share
|
|
Dec 08
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,991
+1.05%
|
$728,686
$146.34 P/Share
|
|
Dec 03
2025
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.83%
|
$502,000
$251.47 P/Share
|
|
Dec 01
2025
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
50
-0.51%
|
$12,200
$244.16 P/Share
|
|
Dec 01
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.13%
|
$244,000
$244.16 P/Share
|
|
Nov 25
2025
|
Jan De Witte Director |
SELL
Open market or private sale
|
Direct |
2,055
-32.54%
|
$524,025
$255.0 P/Share
|
|
Nov 20
2025
|
John Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+17.33%
|
-
|
|
Nov 20
2025
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,848
+5.99%
|
-
|
|
Nov 20
2025
|
Nicole Mowad Nassar Director |
BUY
Grant, award, or other acquisition
|
Direct |
536
+40.82%
|
-
|
|
Nov 20
2025
|
Desney Tan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+15.17%
|
-
|
|
Nov 20
2025
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+8.93%
|
-
|
|
Nov 20
2025
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+9.19%
|
-
|
|
Nov 20
2025
|
Carol Burt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+33.23%
|
-
|
|
Nov 20
2025
|
Ronald R Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+4.15%
|
-
|
|
Nov 20
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,297
-1.54%
|
-
|
|
Nov 20
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,551
+2.78%
|
-
|
|
Nov 20
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,710
+2.97%
|
-
|
|
Nov 20
2025
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
536
+0.75%
|
-
|
|
Nov 20
2025
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+14.52%
|
-
|
|
Nov 20
2025
|
Christopher Del Orefice Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,073
+30.69%
|
-
|
|
Nov 14
2025
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,314
-9.43%
|
$1,784,616
$244.46 P/Share
|
|
Nov 14
2025
|
Peter C Farrell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,442
+12.86%
|
$1,155,642
$101.64 P/Share
|
|
Nov 12
2025
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.94%
|
$504,000
$252.05 P/Share
|
|
Nov 11
2025
|
Harjit Gill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
38
-0.38%
|
$9,500
$250.1 P/Share
|
|
Nov 11
2025
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-0.24%
|
$40,500
$250.1 P/Share
|
|
Nov 11
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,895
-0.57%
|
$1,973,750
$250.1 P/Share
|
|
Nov 11
2025
|
Jan De Witte Director |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-1.43%
|
$19,000
$250.1 P/Share
|
|
Nov 11
2025
|
Jan De Witte Director |
SELL
Open market or private sale
|
Direct |
487
-8.39%
|
$121,750
$250.25 P/Share
|
|
Nov 11
2025
|
Michael J Rider Global General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,523
-3.51%
|
$380,750
$250.1 P/Share
|
|
Nov 07
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Open market or private sale
|
Direct |
8,011
-1.68%
|
$1,994,739
$249.75 P/Share
|
|
Nov 07
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,011
+0.83%
|
$809,111
$101.64 P/Share
|
|
Nov 03
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.38%
|
$741,000
$247.54 P/Share
|
|
Nov 03
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.2%
|
$202,000
$101.64 P/Share
|
|
Oct 07
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Open market or private sale
|
Direct |
8,009
-1.68%
|
$2,258,538
$282.85 P/Share
|
|
Oct 07
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,009
+1.66%
|
$808,909
$101.64 P/Share
|
|
Oct 01
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.34%
|
$822,000
$274.36 P/Share
|
|
Oct 01
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.18%
|
$202,000
$101.64 P/Share
|
|
Oct 01
2025
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
100
-0.88%
|
$27,400
$274.36 P/Share
|
|
Sep 08
2025
|
Michael J. Farrell Chairman and CEO |
SELL
Open market or private sale
|
Direct |
8,009
-1.68%
|
$2,226,502
$278.14 P/Share
|
|
Sep 08
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,009
+1.66%
|
$808,909
$101.64 P/Share
|
|
Sep 02
2025
|
Nicole Mowad Nassar Director |
BUY
Grant, award, or other acquisition
|
Direct |
241
+50.0%
|
-
|
|
Sep 02
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.31%
|
$810,000
$270.77 P/Share
|
|
Sep 02
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.16%
|
$202,000
$101.64 P/Share
|
|
Aug 18
2025
|
John Hernandez Director |
SELL
Open market or private sale
|
Direct |
2,575
-38.9%
|
$739,025
$287.1 P/Share
|
|
Aug 18
2025
|
John Hernandez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,575
+28.0%
|
$381,100
$148.9 P/Share
|
|
Aug 15
2025
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,462
+16.73%
|
-
|
|
Aug 15
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,462
+5.8%
|
-
|
|
Aug 15
2025
|
Michael J. Farrell Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,289
+2.56%
|
-
|